Financial Reports
Related Searches:
Filter by:
346 - 360 of 673 results
January 26, 2010
Product sales were up 2% to $3.7 billion in 4Q09.
Read More »
January 26, 2010
Consolidated service revenue for quarter was $221.6 million in Clinical Research Services (CRS), $29.7 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $33.4 million in Perceptive Informatics, Inc.
Read More »
December 18, 2009
Full-year revenues down 9% between commercial and development service groups.
Read More »
November 5, 2009
Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).
Read More »
November 5, 2009
CRO business revenues were $36.9 million in the quarter (-28%).
Read More »
November 3, 2009
Product sales in the quarter were down 1% to $28.6 million.
Read More »
November 3, 2009
Pharmaceutical Systems segment sales for the third quarter of were $198.1 million (+4%).
Read More »
October 30, 2009
Pharmaceutical sales were up 6% to $9.3 billion in the quarter and YTD sales rose 4% to $28.5 billion.
Read More »
October 30, 2009
Eli Lilly and Co. has opened its new Biotechnology Center in San Diego, as part of its strategy to develop more biopharmaceuticals.
Read More »
October 29, 2009
Sales of Influenza A (H1N1) vaccine totaled $152 million in the quarter. Nexium sales were down 5% to $1.2 billion.
Read More »
October 29, 2009
In the quarter, Diabetes care sales were $1.8 billion (+12%). Biopharmaceutical sales were $636.3 (+10%).
Read More »
October 29, 2009
Specialty pharmaceuticals sales were up 8% in the quarter to $940.6 million, while medical devices sales were down 11% to $187.2 million.
Read More »
October 28, 2009
Development segment revenue for the quarter was $315.8 million (-12%), and income from operations was $52.2 million (-25%).
Read More »
October 27, 2009
In the quarter, Global Specialty Injectables revenue was $575.7 million (+24%).
Read More »
346 - 360 of 673 results
